D-1099-2020 Class II Terminated
FDA drug recall D-1099-2020 was initiated by Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy on March 26, 2020 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated January 29, 2024). Affected quantity: N/A.
Recall Details
- Product Type
- Drugs
- Report Date
- April 15, 2020
- Initiation Date
- March 26, 2020
- Termination Date
- January 29, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Product Description
Alprostadil 10mcg/Papaverine 30mg/Phentolamine 1mg/ml lnj Soln, 5 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA 92562 951-304-9530
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Patient Distribution list includes addresses in the following states: CA, ME, TX
Code Information
Lot #02282020@30, Expires after 04/28/2020